Key facts
- This page summarizes New Enterprise Associates 16, L.P.'s Form 4 filing for Marker Therapeutics, Inc. (MRKR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Dec 2024, 16:40.
New Enterprise Associates 16, L.P. - 23 Dec 2024 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- MRKR
- Reported as of
- 23 Dec 2024
- Net transaction value
- +$1,773,600
- SEC form
- 4
- Accepted by SEC
- 23 Dec 2024, 16:40:48 UTC
- Prior SEC filing
- 03 Oct 2024
- Next SEC filing
- 06 Oct 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Zachary Bambach, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
New Enterprise Associates 16, L.P. filed Form 4 for Marker Therapeutics, Inc. (MRKR) on 23 Dec 2024.
Change
- Previous filing in this sequence was filed on 03 Oct 2024.
- Current net transaction value: +$1,773,600.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MRKR
transaction
Common Stock
Purchase
- Transaction value
- $1,773,600
- Shares
- +554,250
- Change %
- +52%
- Price
- $3.20
- Shares after
- 1,625,678
- Date
- 23 Dec 2024
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Acquired from the Issuer on December 23, 2024 pursuant to a Securities Purchase Agreement dated December 19, 2024.
Footnote F2
On January 26, 2023, the Issuer effected a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
Footnote F3
The securities are directly held by New Enterprise Associates 16, L.P. ("NEA 16"), and indirectly held by NEA Partners 16, L.P. ("NEA Partners 16"), the sole general partner of NEA 16, NEA 16 GP, LLC ("NEA 16 GP"), the sole general partner of NEA Partners 16, and the individual managers of NEA 16 GP (NEA Partners 16, NEA 16 GP and the individual managers of NEA 16 GP, together, the "Indirect Reporting Persons").The individual managers of NEA 16 GP are Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad Makhzoumi, Scott D. Sandell, and Paul Walker. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares of the Issuer held by NEA 16 in which the Indirect Reporting Persons have no pecuniary interest.